Drugmaker EirGen thinks plan to put waste station nearby stinks

A small Irish drugmaker says putting a waste transfer station next to its drug manufacturing plant might contaminate its cancer drugs and force it to close the plant. EirGen Pharma has complained to authorities in Waterford that the proposal by another company to open the transfer complex about 200 yards from its oncology drug plant could have a "profound negative impact of the development on our present and future business," the Irish Times reports. The company says it cannot easily move its regulator-approved plant and its 65 employees. The company says a waste transfer station might create fumes and dust that could overload its air-handling system and odors "could potentially taint the product, which would be rejected with significant financial impact on the company." Story

Suggested Articles

Cambrex has completed installation of multiple continuous flow reactor platforms at its facility in High Point, North Carolina.

Australia’s Mayne Pharma has opened its $80 million oral solid-dose manufacturing facility in Greenville, North Carolina.

GE is launching its prefab line of drug manufacturing units that will help biopharma companies produce viral vector-based vaccines.